In the news

The CDC reported that the outbreak of Salmonella in Charcuterie meats is over. A total of 104 people were infected with the outbreak strain of Salmonella, and 27 were hospitalized In 33 states. Illnesses started from November 20, 2023, to February 10, 2024. Of 92 people with information available, 27 were hospitalized. No deaths were reported. Of 68 people interviewed, 50 (74%) sick people reported eating a variety of charcuterie meats. 25 people provided specific information or shopper card records, all of which reported brands of charcuterie meats produced by Fratelli Beretta. The outbreak strain was found in one package of Fratelli Beretta charcuterie products. The outbreak investigation is over but recalled products have a six-month shelf life. The recalled products were sold nationwide under many brands, including Aldi, Beretta, Black Bear, Busseto, Culinary Tour, Dietz and Watson, Lidl, Publix, and Salumi Artigianali. @ https://www.cdc.gov/salmonella/charcuterie-meats-01-24/index.html

On April 03, 2024, the FDA approved Zevtera (ceftobiprole medocaril sodium for injection) for the treatment of adults with Staphylococcus aureus in bacteremia (SAB), including those with right-sided infective endocarditis; adults with acute bacterial skin and skin structure infections (ABSSSI); and adult and pediatric patients three months to less than 18 years old with community-acquired bacterial pneumonia (CABP). Today’s approval of Zevtera  in pediatric patients three months to less than 18 years with CABP was supported by evidence from the CABP trial of Zevtera in adults and a trial in 138 pediatric subjects three months to less than 18 years of age with pneumonia. Patients should not use Zevtera if they have a history of severe hypersensitivity to ceftobiprole, any of the components of Zevtera, or other members of the cephalosporin antibacterial class. Zevtera was granted Priority Review, Fast Track, and Qualified Infectious Disease Product designations for the CABP, ABSSSI, and SAB indications. @ https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-three-different-uses?utm_medium=email&utm_source=govdelivery

The FDA reported on 03/29/2024 that  AvKARE, LLC. is voluntarily recalling lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product found during stability testing at a 3rd party lab. Atovaquone Oral Suspension, USP is indicated for the prevention and treatment of Pneumocystis jiroveci pneumonia (PCP) in adults and children 13 years of age and older who cannot tolerate other medicines, such as trimethoprim-sulfamethoxazole. Packaged in a carton, the product was distributed nationwide between 03/18/2024 and 03/21/2024 to wholesalers. @ https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/avkare-llc-issues-voluntary-nationwide-recall-atovaquone-oral-suspension-usp-750-mg5-ml-due?utm_medium=email&utm_source=govdelivery

The FDA reported that  Tropicale Foods (Modesto, CA) is voluntarily recalling 5,224 units of Helados Mexico Mini Cream Variety Pack with best by date of “MO Best By 10/11/2025” because the mango bars in the variety pack have the potential to be contaminated with Salmonella. The product was distributed at retail locations in Iowa, Illinois, Indiana, Kentucky, Massachusetts, Maryland, Maine, Michigan, North Carolina, New Hampshire, Rhode Island, South Carolina, Tennessee, Virginia, Wisconsin, West Virginia, Washington, DC, and certain European locations. No illnesses have been reported to date. Tests of the finished product on the mango bars revealed that the finished product may contain Salmonella. The company has ceased distribution of the affected product, is investigating what caused the problem, and will take effective action to prevent future issues. @ https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/tropicale-foods-recalls-helados-mexico-mini-cream-variety-pack-because-possible-health-risk#:~:text=Tropicale%20Foods%20of%20Modesto%2C%20CA,serious%20and%20sometimes%20fatal%20infections